NEOG » Topics » FISCAL YEAR-END OPTION VALUES

This excerpt taken from the NEOG DEF 14A filed Sep 11, 2006.

FISCAL YEAR-END OPTION VALUES

 

     Shares
Acquired
On Exercise


   Value
Realized (1)


   Number of Unexercised
Options
at May 31, 2005


   Value of Unexercised
In-The-Money Options
at May 31, 2005 (2)


Name


         Exercisable

   Unexercisable

   Exercisable

   Unexercisable

James L. Herbert

   58,707    $ 754,141    99,970    53,726    $ 895,287    $ 356,135

Lon M. Bohannon

   22,500      319,225    20,744    77,257      134,396      330,264

Richard R. Current

   7,500      82,875    30,959    50,541      236,059      240,171

Edward L. Bradley

   7,500      83,588    43,063    47,188      369,446      219,044

Terri A. Morrical

   7,500      82,875    42,249    49,002      357,508      232,968

(1) Represents the difference between the market price of the Common Stock and the exercise price of the options on the date of exercise multiplied by the number of shares acquired upon exercise.
(2) Represents the difference between the closing market price of Common Stock at May 31, 2006 of $20.40 per share and the exercise price per share of in-the-money options multiplied by the number of shares which could be acquired upon the exercise of all in-the-money options.

 

Compensation of Directors

 

The Company does not pay director’s fees to any director for attendance at meetings of the Board or standing Committees. All non-employee directors are granted non-qualified options to purchase 5,000 shares of Common Stock when first elected to the Board of Directors and non-qualified options to purchase 2,000 shares of Common Stock upon subsequent election to, or commencement of annual service on, the Board of Directors. The options expire ten years after the date of grant and vest over three years in equal annual installments commencing with the first anniversary of the date of grant. All directors are eligible to receive reimbursement for all ordinary travel expenses related to attendance at Board or committee meetings.

 

11


This excerpt taken from the NEOG DEF 14A filed Sep 9, 2005.

FISCAL YEAR-END OPTION VALUES

 

     Shares
Acquired
On Exercise


   Value
Realized (1)


   Number of Unexercised
Options
at May 31, 2005


   Value of Unexercised
In-The-Money Options
at May 31, 2005 (2)


Name


         Exercisable

   Unexercisable

   Exercisable

   Unexercisable

James L. Herbert

   30,549    $ 412,300    64,279    159,844    $ 340,283    $ 956,279

Lon M. Bohannon

   13,000      147,800    40,343    41,658      208,158      207,107

Richard R. Current

   5,000      80,995    26,498    12,750      135,551      74,440

Edward L. Bradley

   3,750      50,550    24,399    23,101      125,727      98,423

Terri A. Morrical

   3,750      50,550    25,751    25,498      132,055      127,641

(1) Represents the difference between the market price of the Common Stock and the exercise price of the options on the date of exercise multiplied by the number of shares acquired upon exercise.
(2) Represents the difference between the closing market price of Common Stock at May 31, 2005 of $14.48 per share and the exercise price per share of in-the-money options multiplied by the number of shares which could be acquired upon the exercise of all in-the-money options.

 

Compensation of Directors

 

The Company does not pay director’s fees to any director for attendance at meetings of the Board or standing committees. All non-employee directors are granted non-qualified options to purchase 5,000 shares of Common Stock when first elected to the Board of Directors and non-qualified options to purchase 2,000 shares of Common Stock upon subsequent election to, or commencement of annual service on, the Board of Directors. The options expire ten years after the date of grant and vest over three years in equal annual installments commencing with the first anniversary of the date of grant. All directors are eligible to receive reimbursement for all ordinary travel expenses related to attendance at Board or committee meetings.

 

11


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki